Although the drug development based on the cGAS–STING signaling pathway is still in its infancy and there are many difficulties, further research on the regulating mechanisms of the cGAS–STING signaling pathway and the development of targeted drugs still provide new strategies and hopes for the targeted therapy of inflammatory diseases and cancers. This evidence concerns the gene CGAS and cancer.